Advancing cell therapy for diabetes

Researchers used single-cell sequencing to identify a protein expressed uniquely by insulin-producing beta cells created from stem cells in the laboratory. By targeting the protein and adding a physical enrichment method, the purity of beta cells improved from 30 to 80%. Improved control over the beta cell production process will allow researchers to refine cell therapy for patients with type 1 diabetes.

from Diseases and Conditions News -- ScienceDaily http://bit.ly/2WwxDvt